This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carlyle Group (CG) have what it takes? Let's find out.
Carlyle (CG) Delays 6th Asia Fund Close as Japan Pool Hits Demand
by Zacks Equity Research
Carlyle (CG) plans to delay the closure of its new pan-Asian buyout fund after strong demand for a Japan-focused vehicle sapped investor interest.
Why Carlyle Group (CG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carlyle Group (CG) have what it takes? Let's find out.
Carlyle Secured Lending (CGBD) Enters Merger Deal With CSL III
by Zacks Equity Research
Carlyle Secured Lending's (CGBD) merger with CSL III is projected to offer significant value and advantages to investors in the short term and over the long run.
Will Blue Owl Capital's (OBDC) Q2 Profits Grow or Decline?
by Zacks Equity Research
Blue Owl Capital's (OBDC) second-quarter results are likely to reflect growing controlled affiliated dividend income.
Carlyle (CG) Stock Falls 7.5% as Q2 Earnings Miss Estimates
by Zacks Equity Research
Carlyle's (CG) second-quarter earnings miss estimates due to a decline in segment fee and realized performance revenues. Nonetheless, a rise in total AUM balance and lower costs are tailwinds.
Company News for Aug 6, 2024
by Zacks Equity Research
Companies In The Article Are:CG, WBA, K and TSN
Market Awaits Services PMI Data
by Zacks Equity Research
Market Awaits Services PMI Data
Pre-Markets Deep in Red, Sell-off in Global Markets Intensifies
by Zacks Equity Research
Pre-Markets Deep in Red, Sell-off in Global Markets Intensifies.
Carlyle (CG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Carlyle (CG) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Curious about Carlyle (CG) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Carlyle (CG) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why Carlyle Group (CG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carlyle Group (CG) have what it takes? Let's find out.
Discover (DFS) Q2 Earnings Beat on High Interest Income
by Zacks Equity Research
Discover's (DFS) management expects the loan growth to be down low single digits this year.
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
by Zacks Equity Research
Shares of Baxter (BAX) are showing signs of stability after falling in the first half of 2024. Let's see what is driving investors' sentiment for the company.
Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit
by Zacks Equity Research
Carlyle Group (CG) is in talks to acquire Baxter's kidney care unit. The companies started exclusive negotiations in late June and an agreement could be announced as soon as this week.
Company News for July 8, 2024
by Zacks Equity Research
Companies In The News Article are: M, LI, BAX, CG and AMD.
Carlyle (CG) Thrives on Organic Growth Amid High Costs
by Zacks Equity Research
Carlyle (CG) is set to benefit from its efforts to grow organically. However, a rise in expenses due to higher compensation-related costs is likely to hinder its bottom-line growth.
Carlyle Group (CG) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carlyle Group (CG) have what it takes? Let's find out.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carlyle Group (CG) have what it takes? Let's find out.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Why Carlyle Group (CG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carlyle Group (CG) have what it takes? Let's find out.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Truist (TFC) Closes TIH Sale, Repositions Balance Sheet
by Zacks Equity Research
Truist (TFC) completes the sale of its subsidiary, TIH, and executes a balance sheet repositioning strategy. Driven by these, the company's 2024 total revenues will be higher than previously expected.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
After Plunging -13.6% in 4 Weeks, Here's Why the Trend Might Reverse for Carlyle (CG)
by Zacks Equity Research
Carlyle (CG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.